Single-Cell Sequencing-Guided Annotation of Rare Tumor Cells for Deep Learning-Based Cytopathologic Diagnosis of Early Lung Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published Date:

Abstract

Deep learning (DL) models for medical image analysis are majorly bottlenecked by the lack of well-annotated datasets. Bronchoalveolar lavage (BAL) is a minimally invasive procedure to diagnose lung cancer, but BAL cytology suffers from low sensitivity. The success of DL in BAL cytology is rare due to the rarity of exfoliated tumor cells (ETCs) and their subtle morphological differences from normal cells. Single-cell DNA sequencing (scDNA-Seq) is utilized as an objective ground truth of ETC annotation for generating an unbiased, accurately annotated dataset comprising 580 ETCs and 1106 benign cells from BAL cytology slides. A DL model is developed, to distinguish ETC from benign cells in BAL fluid, achieving an Area Under the Curve of 0.997 and 0.956 for detecting large- and small-sized ETCs, respectively. The model is applied in a discovery cohort (n = 156) to establish BAL-based cytopathologic diagnostic model for lung cancer. The model is evaluated in a validation cohort (n = 158), and yielded 47.6% sensitivity and 97.7% specificity in lung cancer diagnosis, outperforming cytology with improved sensitivity (47.6% vs 19.0%). In an external validation cohort (n = 141), the model achieved 60.0% sensitivity and 92.5% specificity in lung cancer diagnosis.

Authors

  • Yichun Zhao
    Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
  • Ruoran Qiu
    Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
  • Zhuo Wang
    Sichuan Center for Disease Control and Prevention, Chengdu 610500, China.
  • Yunyun Li
    Department of Pathology, The First Affiliated Hospital (Qingchun campus), Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Xu Yang
    Department of Food Science and Technology, The Ohio State University, Columbus, OH, United States.
  • Yanlin Li
    Department of Electrical Engineering and Automation, Anhui University, Hefei 230601, China. Electronic address: LYLAU1314@163.com.
  • Xiaohan Shen
    Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Yun Liu
    Google Health, Palo Alto, CA USA.
  • Ziqiang Chen
  • Qihan You
    Department of Pathology, The First Affiliated Hospital (Qingchun campus), Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Qihui Shi
    Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.